Skip to main content
Signal8

BioNexus Gene Lab Corp (BGLC)

BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.

Sector: Services-Medical Laboratories

Industry: Industrial - Distribution

BioNexus Gene Lab Corp. logo

BioNexus Gene Lab Corp.

NASDAQ:BGLCIndustrials
AH-2.00%$0.7509
Close$0.7662-6.56%
Mkt Cap$2.25M
EV-
Float1.24M
O/S2.93M
VOL14K sh
$ Vol$10K
RVOL2.52×
Inst Own0.0%
SI0.3%
Net Cash/Sh-
Dilution
BioNexus Gene Lab Corp. logoNASDAQ:BGLCAH$0.7509-2.00%
Short interest (FINRA)
0.3%
Oct 30 (18d)

Float 1.24M · Signal8 dilution snapshot · Aug 14, 2026

3.2K
Oct 30 (18d)prev 9.1K▼ 64.9%
1.00
Oct 30 (18d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow BGLC shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
88.3%
Nov 16 (1d)prev 1.1%▲ 87.2 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

597
Sep 24 (54d)prev 37▲ 1513.5%
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Fails to deliver22 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 20263.2K sh
Oct 15, 20269.1K sh
Sep 30, 202610.1K sh
Sep 15, 202613.0K sh
Aug 31, 20267.5K sh
Latest fails to deliver
DateShares failed
Sep 24, 2026597 sh
Sep 23, 202637 sh
Sep 22, 202613 sh
Sep 21, 20262.1K sh
Sep 10, 2026675 sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 16
Latest sessions
DateReported short
Nov 16, 202688.3%
Nov 13, 20261.1%
Nov 12, 202676.7%
Nov 11, 202676.2%
Nov 10, 202615.3%
89-session median 38.2%mean 40.3%range 0.6–99.6%

130 calendar days requested; 90 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for BGLC: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 3,180 BGLC shares were sold short (0.26% of a 1.24M-share float, 1.00 days to cover).